M&A Activity Up Year-Over-Year, Driven By Tax-Inversion Deals And Diversification
This article was originally published in The Pink Sheet Daily
Executive Summary
The Actavis/Forest deal was the largest deal in the first quarter, but was among 62 deals in total that were signed in the biopharma sector during the quarter.